| Year | Title | Author |
|---|---|---|
| 2022 | The natural sulfoglycolipid derivative SQAP improves the therapeutic efficacy of tissue factor-targeted radioimmunotherapy in the stroma-rich pancreatic cancer model BxPC-3./Transl Oncol. 2022 Jan;15(1):101285. | Takakusagi Y, Sugyo A, Tsuji AB, Sudo H, Yasunaga M, Matsumura Y, Sugawara F, Sakaguchi K, Higashi T. |
R&D Library
- TOP
- R&D Library
- The natural sulfoglycolipid derivative SQAP improves the therapeutic efficacy of tissue factor-targeted radioimmunotherapy in the stroma-rich pancreatic cancer model BxPC-3./Transl Oncol. 2022 Jan;15(1):101285.
- TOP
- R&D Library
- The natural sulfoglycolipid derivative SQAP improves the therapeutic efficacy of tissue factor-targeted radioimmunotherapy in the stroma-rich pancreatic cancer model BxPC-3./Transl Oncol. 2022 Jan;15(1):101285.
